https://www.selleckchem.com/pr....oducts/fatostatin.ht
th better survival time in patients with liver cancer. Moreover, nomograms for predicting prognosis may help to estimate the survival of patients. propose that CXCL8 and CXCL1 may be a potential therapeutic target for liver cancer treatment. High and/or intermediate immune scores are significantly correlated with better survival time in patients with liver cancer. Moreover, nomograms for predicting prognosis may help to estimate the survival of patients. We also propose that CXCL8 and CXCL1 may be a potential therapeutic target for l
Like
Comment
Share
